Exciting new products at AudiologyNOW!
Staefa (Switzerland), 03.04.2013 - At this year's AudiologyNOW! congress held
in Anaheim, California 3-6 April 2013, Sonova will unveil a range of new
products under all of its product brands, reflecting the group's high pace of
innovation. With the launch of Phonak Audéo Q and Phonak Naída Q, Phonak will
expand its range of products based on the Quest platform. Unitron will
showcase its newest Receiver-In-Canal (RIC) hearing instrument Moxi Kiss and
Advanced Bionics announces the approval of its new HiFocus Mid-Scala1
electrode in Europe and Canada and the worldwide regulatory approval of its
new HiRes Optima2 sound processing innovation.
"We are very excited about the broad range of new products showcased by all
three product brands at this year's congress", says Lukas Braunschweiler, CEO
of Sonova. "We believe that they clearly reflect Sonova's goal to constantly
challenge the limits of technology and its mission to be recognized as the
innovation leader in the global hearing care market. We are convinced that the
new products will support our goal to further grow our market share while at
the same time expanding the group's profitability", adds Braunschweiler.
Phonak introduces the new Phonak Audéo Q and Phonak Naída Q portfolio, based
on the Quest platform launched six months ago. With the introduction of the
new RIC and power portfolio, Phonak further expands the Quest platform with
two new product lines and now offers targeted solutions for all degrees of
hearing loss. Both product families feature the unique Binaural VoiceStream
Technology and will be available in the market with immediate effect. Phonak
Audéo Q enhances the spontaneous acceptance and enables more signal, less
noise and better understanding in more listening situations - even with open
fit. The new Tinnitus Balance Portfolio - available with Phonak Audéo Q -
offers hearing care professionals essential tools to support a variety of
tinnitus management philosophies. The Phonak Naída Q product family delivers
premium performance for people with severe to profound hearing loss.
Furthermore, Phonak introduces Roger, a new digital standard that bridges the
understanding gap, in noise and over distance, by wirelessly transmitting the
speaker's voice directly to the listener. Available for the education market
from June 2013, Roger surpasses all of today's FM and equivalent digital
systems. It offers a scientifically proven3 breakthrough in signal-to-noise
ratio and finally eliminates the hassle of frequency management.
On March 18, 2013 Unitron announced Moxi Kiss, its newest RIC hearing
instrument with a design aimed at improving patient acceptance.
Moxi Kiss represents an evolution in design for Unitron's Moxi product family,
putting the comfort of the patient at the forefront. Designed to look great in
the hand and provide maximum visual appeal for the first time wearer, Moxi
Kiss delivers the perfect balance of fit, finish, and colour. Moxi Kiss
continues to deliver on the high fidelity natural sound Unitron's Moxi product
family has come to stand for.
Moxi Kiss is available through the new Flex:trial program, a unique product
and service concept only available from Unitron that offers hearing care
professionals a risk-free opportunity to demonstrate the benefits of hearing
instruments. Patients wear a personalized Moxi Kiss Flex:trial device home
after the first appointment for a trial period, allowing them to experience
the benefits in real, everyday situations. Experiencing the benefits of
wearing Moxi Kiss without risk or obligation helps to reduce any uncertainty
while immediately improving the quality of life for those patients.
AB announced that it received TÜV and Health Canada approval for the HiFocus
Mid-Scala1 electrode over the course of the past two months. The new HiFocus
Mid-Scala array is the latest innovation in electrode design. It has been
designed for optimal mid-scala placement in the cochlea to protect its
delicate structures. Featuring the industry's smallest pre-curved array, the
HiFocus Mid-Scala is the only pre-curved electrode developed for the latest
soft surgery approaches and to fit safely in each individual cochlea.
AB also announced worldwide approval of the new HiRes Optima2 sound processing
innovation. This advanced hearing technology delivers optimized battery life
with the same great performance as AB's patented HiRes Fidelity 1202
processing. AB cochlear implant recipients using this new technology enjoy an
average improvement of 55% in battery life, giving them considerably more time
to hear their world before needing to change a battery.
1Pending regulatory approval in the United States.
2Not approved for pediatric use in the United States.
3Comparison of speech recognition with adaptive digital and FM wireless
technology by listeners who use hearing aids.
Professor Linda Thibodeau PhD.
- End -
Phone +41 58 928 33 44
Mobile +41 79 618 28 07
Contacts Investor Relations
Phone +41 58 928 33 22
Phone +41 58 928 33 24
Mobile +41 79 420 29 56
This Media Release contains forward-looking statements, which offer no
guarantee with regard to future performance. These statements are made on the
basis of management's views and assumptions regarding future events and
business performance at the time the statements are made. They are subject to
risks and uncertainties including, but not confined to, future global economic
conditions, exchange rates, legal provisions, market conditions, activities by
competitors and other factors outside Sonova's control. Should one or more of
these risks or uncertainties materialize or should underlying assumptions
prove incorrect, actual outcomes may vary materially from those forecasted or
expected. Each forward-looking statement speaks only as of the date of the
particular statement, and Sonova undertakes no obligation to publicly update
or revise any forward-looking statements, except as required by law.
Sonova Holding AG, headquartered in Staefa, Switzerland, is the leading
manufacturer of innovative hearing care solutions. The group operates through
its core business brands Phonak, Unitron, Advanced Bionics and Connect
Hearing. Sonova offers its customers one of the most comprehensive product
portfolios in the industry - from hearing instruments to cochlear implants to
wireless communication solutions. Founded in 1947, the group is currently
present in over 90 countries across the globe and has a workforce of over
8,500 dedicated employees. Sonova generated sales of CHF 1,62 billion in the
financial year 2011/12 and a net profit of CHF 246 million. By supporting the
Hear the World Foundation, Sonova pursues its vision of a world where everyone
enjoys the delight of hearing and therefore lives a life without limitations.
For more information please visit www.sonova.com and www.hear-the-world.com.
Sonova shares (ticker symbol:SOON, Security no: 1254978, ISIN: CH1012549785)
have been listed on the SIX Swiss Exchange since 1994. The securities of
Sonova have not been and will not be registered under the U.S. Securities Act
of 1933, as amended (the "U.S. Securities Act"), or under the applicable
securities laws of any state of the United States of America, and may not be
offered or sold in the United States of America except pursuant to an
exemption from the registration requirements under the U.S. Securities Act and
in compliance with applicable state securities laws, or outside the United
States of America to non-U.S. Persons in reliance on Regulation S under the
U.S. Securities Act.
Sonova Media Release (PDF)
Phonak - Media Release Phonak Audéo Q and Phonak Naída Q (PDF)
Phonak - Media Release Roger for Education (PDF)
Unitron - Media Release Moxi Kiss (PDF)
AB - Media Release HiFocus Mid-Scala Electrode (PDF)
AB - Media Release HiRes Optima sound processing (PDF)
Provider Channel Contact
Tensid Ltd., Switzerland newsbox.ch Provider/Channel related enquiries
www.tensid.ch www.newsbox.ch email@example.com
+41 41 763 00 50
Press spacebar to pause and continue. Press esc to stop.